| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | CYP1A2 |
| Uniprot No | P05177 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-516aa |
| 氨基酸序列 | ALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARLRFSIN |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于CYP1A2重组蛋白的3篇代表性文献摘要概括：
1. **《Heterologous expression of human cytochrome P450 1A2 in Escherichia coli: purification, characterization, and catalytic activity》**
- 作者：Guengerich, F.P., et al.
- 摘要：研究报道了人CYP1A2在大肠杆菌中的异源表达和纯化方法，分析了重组蛋白的酶活性，证实其可代谢典型底物(如菲那西汀和咖啡因)，并探讨了血红素插入对功能的影响。
2. **《Functional characterization of human cytochrome P450 1A2 in insect cells: comparison with recombinant enzyme expressed in E. coli》**
- 作者：Hanna, I.H., et al.
- 摘要：对比了昆虫细胞(杆状病毒系统)和大肠杆菌表达的CYP1A2重组蛋白，发现两者在底物代谢动力学(如茶碱氧化)和热稳定性方面存在差异，提示表达系统影响酶性质。
3. **《Structural basis of ligand binding to CYP1A2: insights from co-crystallization with inhibitors》**
- 作者：Sansen, S., et al.
- 摘要：通过重组CYP1A2与抑制剂(如α-萘黄酮)的共结晶，解析了其三维结构，揭示了活性位点的关键氨基酸残基与配体结合模式，为药物相互作用研究提供结构基础。
注：以上文献标题和作者为示例性概括，实际文献检索建议通过PubMed或SciFinder核实具体信息。
**Background on CYP1A2 Recombinant Protein**
Cytochrome P450 1A2 (CYP1A2) is a member of the cytochrome P450 enzyme superfamily, primarily expressed in the liver, where it plays a critical role in the metabolism of xenobiotics and endogenous compounds. This enzyme is involved in the oxidative breakdown of approximately 10-15% of clinically used drugs, including caffeine, clozapine, and theophylline, as well as environmental procarcinogens like heterocyclic amines and polycyclic aromatic hydrocarbons. Its activity is influenced by genetic polymorphisms, environmental factors (e.g., smoking), and drug interactions, leading to interindividual variability in drug response and toxicity risks.
Recombinant CYP1A2 protein is produced using biotechnological methods, often through heterologous expression in systems like *E. coli*, yeast, or insect cells. These systems enable large-scale production of the enzyme for *in vitro* studies, bypassing challenges associated with isolating it from human tissues. The recombinant protein retains catalytic activity, allowing researchers to study substrate specificity, inhibition kinetics, and metabolic pathways in controlled environments.
Research applications of recombinant CYP1A2 include drug development, toxicity screening, and mechanistic studies of enzyme induction or inhibition. For instance, it is used to assess drug-drug interactions, evaluate metabolite formation, and characterize genetic variants affecting enzyme function. Additionally, CYP1A2 is induced by aryl hydrocarbon receptor (AhR) agonists, such as dioxins, linking it to environmental toxicology studies.
Structural studies using recombinant CYP1A2 have provided insights into its active site architecture and substrate-binding mechanisms, facilitating the design of safer drugs and personalized therapies. Its role in activating procarcinogens also underscores its relevance in cancer research. Overall, recombinant CYP1A2 serves as a vital tool for advancing pharmacology, toxicology, and precision medicine.
×
